Description: Cynata’s Cymerus™ technology addresses the complexities and challenges of manufacturing stem cells at commercial scale.
Mesenchymal stem cells (MSCs) have huge therapeutic potential for numerous unmet medical needs.
This has already been demonstrated and is widely documented.
Cynata’s unique Cymerus™ technology addresses many of the complexities and challenges of manufacturing these cells at commercial scale.